Table 2. Comparison of admissions during the pre-pandemic and pandemic study periods.
Variable | Classification | Pre-pandemic | Pandemic | p* |
---|---|---|---|---|
Rutherford | 2 | 4 (3.1%; 3%) | 1 (0.6%; 1.1%) | |
3 | 50 (39.1%; 8.5%) | 11 (6.2%; 3.5%) | ||
4 | 24 (18.8%; 6.8%) | 43 (24.2%; 6.3%) | ||
5 | 40 (31.3%; 8%) | 100 (56.2%; 7.3%) | ||
6 | 10 (7.8%; 4.6%) | 23 (12.9%; 4.9%) | <0.001 | |
Amputation | No | 503 (93.5%; 2.1%) | 393 (77.8%; 3.6%) | |
Yes | 35 (6.5%; 2.1%) | 112 (22.2%; 3.6%) | <0.001 | |
Amputation classification (restricted to amputation cases) | Minor | 25 (71.4%; 15%) | 73 (65.2%; 8.8%) | |
Major | 10 (28.6%; 15%) | 39 (34.8%; 8.8%) | 0.544 | |
Diagnosis | PAOD | 110 (20.4%; 3,4%) | 124 (24.6%; 3.8%) | |
Diabetic foot | 27 (5%;1.8%) | 83 (16.4%; 3.2%) | ||
PAOD + diabetic foot | 8 (1.5%; 1%) | 38 (7.5%; 2.3%) | ||
Others | 393 (73%; 3.7%) | 260 (51.5%; 4.4%) | <0.001 | |
PAOD | No | 420 (78.1%; 3.5%) | 343 (67.9%; 4.1%) | |
Yes | 118 (21.9%; 3.5%) | 162 (32.1%; 4.1%) | <0.001 | |
Diabetic foot (with or without PAOD) | No | 503 (93.5%; 2.1%) | 384 (76.0%; 3.7%) | |
Yes | 35 (6.5%; 2.1%) | 121 (24.0%; 3.7%) | <0.001 |
PAOD: peripheral arterial occlusive disease.
Fisher’s exact test or chi-square test, p<0.05.